What is CANF's relative strength rating?

CANF ranks at the 60th percentile over 1 month, 45th percentile over 3 months, 19th percentile over 6 months, 8th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is CANF in?

CANF is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is CANF in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). CANF benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is CANF?

CANF currently shows a 20-day average daily range (ADR%) of 4.6%, a 90-day beta versus the S&P 500 of 0.72. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does CANF have a seasonal pattern?

TickerStance computes CANF's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what CANF has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did CANF last report earnings?

No SEC EDGAR filings are linked to CANF in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Free

CANF · RS 45 · PWR 38

Power rating ↑RS percentile →

One point among 5,323 · As of Monday, August 24, 2026, posted ~17:00 ET

CANF

CANF is not confirmed as a leader. 45 is not yet a leadership-grade RS read, Market Stance is 47.8

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) — Stance & relative strength

Healthcare · Pharmaceutical Products

$3.35▲ +0.60% todayUSD · close

▼ Stance 48 · Neutral

CANF$3.35▲ +0.60%

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) has a 3-month relative strength percentile of 45 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 38. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.6%, relative volume 0.74×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month45pctile

6 month19pctile

1 year8pctile

Classic14IBD pctile

LDR3leadership

0 of 5 lenses lit · avg RS pctile 18

!ADR%4.6%✓A/DA!RVOL0.74×!$ Vol$7M

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · CANF

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
CANF
45RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

IONSIonis Pharmaceuticals, Inc. Common Stock19 BONBon Natural Life Limited Class A Ordinary Shares19 ANVSAnnovis Bio, Inc.19 MNKDMannkind Corporation19

Public attention · CANF

Is the crowd watching?

38/ 100 · vs its own 90-day norm▲ 21 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out2.1Mshares

Market cap$7.2MNano Cap

FAQ

Frequently asked questions

What is CANF's relative strength rating?: CANF ranks at the 60th percentile over 1 month, 45th percentile over 3 months, 19th percentile over 6 months, 8th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is CANF in?: CANF is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is CANF in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). CANF benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is CANF?: CANF currently shows a 20-day average daily range (ADR%) of 4.6%, a 90-day beta versus the S&P 500 of 0.72. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does CANF have a seasonal pattern?: TickerStance computes CANF's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what CANF has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Loading ticker…

CANF monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	CANF Jan avg: -11.31% median: -6.51% win: 25% σ: 14.59% n: 4 2022-04-12 → 2026-07-31	CANF Feb avg: 1.06% median: 9.94% win: 75% σ: 25.09% n: 4 2022-04-12 → 2026-07-31	CANF Mar avg: -15.60% median: -15.70% win: 25% σ: 15.71% n: 4 2022-04-12 → 2026-07-31	CANF Apr avg: -14.81% median: -19.83% win: 20% σ: 12.47% n: 5 2022-04-12 → 2026-07-31	CANF May avg: 13.39% median: 5.02% win: 80% σ: 20.36% n: 5 2022-04-12 → 2026-07-31	CANF Jun avg: 2.51% median: -2.08% win: 40% σ: 11.77% n: 5 2022-04-12 → 2026-07-31	CANF Jul avg: -3.58% median: -1.63% win: 40% σ: 22.02% n: 5 2022-04-12 → 2026-07-31	CANF Aug avg: -6.40% median: -4.20% win: 25% σ: 18.04% n: 4 2022-04-12 → 2026-07-31 (current)	CANF Sep avg: -9.84% median: -9.66% win: 0% σ: 6.60% n: 4 2022-04-12 → 2026-07-31	CANF Oct avg: -8.72% median: -8.21% win: 50% σ: 22.18% n: 4 2022-04-12 → 2026-07-31	CANF Nov avg: -0.65% median: -0.69% win: 50% σ: 13.60% n: 4 2022-04-12 → 2026-07-31	CANF Dec avg: -25.63% median: -26.57% win: 0% σ: 14.99% n: 4 2022-04-12 → 2026-07-31

CANF monthly seasonality strip

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

CANF Jan avg: -11.31% median: -6.51% win: 25% σ: 14.59% n: 4 2022-04-12 → 2026-07-31

CANF Feb avg: 1.06% median: 9.94% win: 75% σ: 25.09% n: 4 2022-04-12 → 2026-07-31

CANF Mar avg: -15.60% median: -15.70% win: 25% σ: 15.71% n: 4 2022-04-12 → 2026-07-31

CANF Apr avg: -14.81% median: -19.83% win: 20% σ: 12.47% n: 5 2022-04-12 → 2026-07-31

CANF May avg: 13.39% median: 5.02% win: 80% σ: 20.36% n: 5 2022-04-12 → 2026-07-31

CANF Jun avg: 2.51% median: -2.08% win: 40% σ: 11.77% n: 5 2022-04-12 → 2026-07-31

CANF Jul avg: -3.58% median: -1.63% win: 40% σ: 22.02% n: 5 2022-04-12 → 2026-07-31

CANF Aug avg: -6.40% median: -4.20% win: 25% σ: 18.04% n: 4 2022-04-12 → 2026-07-31 (current)

CANF Sep avg: -9.84% median: -9.66% win: 0% σ: 6.60% n: 4 2022-04-12 → 2026-07-31

CANF Oct avg: -8.72% median: -8.21% win: 50% σ: 22.18% n: 4 2022-04-12 → 2026-07-31

CANF Nov avg: -0.65% median: -0.69% win: 50% σ: 13.60% n: 4 2022-04-12 → 2026-07-31

CANF Dec avg: -25.63% median: -26.57% win: 0% σ: 14.99% n: 4 2022-04-12 → 2026-07-31

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) — Stance & relative strength

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) — Stance & relative strength

CANF is not confirmed as a leader. 45 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) — Stance & relative strength

CANF is not confirmed as a leader. 45 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?